Jim Abraham currently serves as Senior Vice President and Chief Data Officer and is responsible for the development of machine learning algorithms via DEAN (Deliberation Analytics), an advanced AI platform that powers Next Generation Profiling™ (NGP™), blood-based diagnostic assay development, drug target discovery, tumor type assessment (the Caris Molecular Disease Classifier), and therapeutic selection.
Jim is an inventor on multiple groundbreaking patents involving novel algorithms and predictive signatures which is ushering in this new era of Next Generation Profiling.
Jim joined Caris Life Sciences in 2007 in Information Technology and has since held several management positions with increasing responsibilities. He began his career developing the vast majority of data models and systems driving Caris’ pursuits in precision medicine today. Jim then moved on to lead the Cognitive Computing group where he was instrumental in helping to identify new biological signatures to improve cancer diagnosis and treatment selection.
Jim earned a bachelor’s degree in Neurobiology from the University of Texas at Austin and pursued his post graduate education in Biomedical Informatics at Stanford University and will complete his PhD in Cell & Molecular Biology at Arizona State University in 2019.